Capone Mark Christopher

CIK 00013524134 companiesSALT LAKE CITY, UT

SEC Profile

Transactions

Companies

Filings

CIK

0001352413

Recent Transactions

50 trades

Purchase
MESA LABORATORIES INC /CO/$MLAB
Common Stock
2026-03-10$76.35/sh+1,301→ 3,429 total
Exercise/Conversion
MESA LABORATORIES INC /CO/$MLAB
Restricted Stock Units - 2
2025-08-15−1,404→ 0 total
Exercise/Conversion
MESA LABORATORIES INC /CO/$MLAB
Common Stock
2025-08-15+1,404→ 2,128 total
Award
MESA LABORATORIES INC /CO/$MLAB
Restricted Stock Units - 3
2025-08-15+2,784→ 2,784 total
Award
MESA LABORATORIES INC /CO/$MLAB
Restricted Stock Units - 2
2024-08-15+1,404→ 1,404 total
Exercise/Conversion
MESA LABORATORIES INC /CO/$MLAB
Common Stock
2024-08-15+724→ 724 total
Exercise/Conversion
MESA LABORATORIES INC /CO/$MLAB
Restricted Stock Units - 1
2024-08-15−724→ 0 total
Award
MESA LABORATORIES INC /CO/$MLAB
Restricted Stock Units -1
2024-02-15+724→ 724 total
Award
DermTech, Inc.
Common Stock
2023-06-01+35,714→ 82,054 total
Award
DermTech, Inc.
Common Stock
2022-07-18+26,480→ 26,480 total
Award
DermTech, Inc.
Common Stock
2022-07-18+19,860→ 46,340 total
Disposition to Issuer
MYRIAD GENETICS INC$MYGN
Common Stock
2019-09-30$28.63/sh−8,727→ 540,511 total
Disposition to Issuer
MYRIAD GENETICS INC$MYGN
Common Stock
2019-09-30$28.63/sh−18,295→ 522,216 total
Disposition to Issuer
MYRIAD GENETICS INC$MYGN
Common Stock
2019-09-25$29.93/sh−15,800→ 567,533 total
Award
MYRIAD GENETICS INC$MYGN
Common Stock
2019-09-25+142,500→ 583,333 total
Disposition to Issuer
MYRIAD GENETICS INC$MYGN
Common Stock
2019-09-25$29.93/sh−18,295→ 549,238 total
Sale
MYRIAD GENETICS INC$MYGN
Common Stock
2019-08-01$44.00/sh−58,138→ 440,833 total
Exercise/Conversion
MYRIAD GENETICS INC$MYGN
Incentive Stock Option (right to buy)
2019-08-01−3,862→ 0 total
Exercise/Conversion
MYRIAD GENETICS INC$MYGN
Incentive Stock Option (right to buy)
2019-08-01−4,328→ 0 total
Exercise/Conversion
MYRIAD GENETICS INC$MYGN
Non-Qualified Stock Option (right to buy)
2019-08-01−58,138→ 0 total
Exercise/Conversion
MYRIAD GENETICS INC$MYGN
Common Stock
2019-08-01$23.11/sh+4,328→ 445,161 total
Exercise/Conversion
MYRIAD GENETICS INC$MYGN
Common Stock
2019-08-01$30.34/sh+3,862→ 444,695 total
Exercise/Conversion
MYRIAD GENETICS INC$MYGN
Common Stock
2019-08-01$30.34/sh+58,138→ 498,971 total
Exercise/Conversion
MYRIAD GENETICS INC$MYGN
Non-Qualified Stock Option (right to buy)
2019-08-01−70,672→ 0 total
Sale
MYRIAD GENETICS INC$MYGN
Common Stock
2019-08-01$44.00/sh−3,862→ 440,833 total
Sale
MYRIAD GENETICS INC$MYGN
Common Stock
2019-08-01$44.00/sh−4,328→ 440,833 total
Sale
MYRIAD GENETICS INC$MYGN
Common Stock
2019-08-01$44.00/sh−70,672→ 440,833 total
Exercise/Conversion
MYRIAD GENETICS INC$MYGN
Common Stock
2019-08-01$23.11/sh+70,672→ 511,505 total
Disposition to Issuer
MYRIAD GENETICS INC$MYGN
Common Stock
2018-09-30$46.00/sh−8,727→ 440,833 total
Disposition to Issuer
MYRIAD GENETICS INC$MYGN
Common Stock
2018-09-30$46.00/sh−18,295→ 449,560 total
Disposition to Issuer
MYRIAD GENETICS INC$MYGN
Common Stock
2018-09-25$46.65/sh−18,295→ 467,855 total
Award
MYRIAD GENETICS INC$MYGN
Common Stock
2018-09-19+165,000→ 486,150 total
Disposition to Issuer
MYRIAD GENETICS INC$MYGN
Common Stock
2018-09-17$46.35/sh−11,025→ 321,150 total
Exercise/Conversion
MYRIAD GENETICS INC$MYGN
Incentive Stock Option (right to buy)
2018-07-11−2,346→ 0 total
Exercise/Conversion
MYRIAD GENETICS INC$MYGN
Common Stock
2018-07-11$30.12/sh+2,346→ 334,521 total
Exercise/Conversion
MYRIAD GENETICS INC$MYGN
Common Stock
2018-07-11$30.12/sh+77,654→ 409,829 total
Sale
MYRIAD GENETICS INC$MYGN
Common Stock
2018-07-11$41.00/sh−77,654→ 332,175 total
Exercise/Conversion
MYRIAD GENETICS INC$MYGN
Non-Qualified Stock Option (right to buy)
2018-07-11−77,654→ 0 total
Sale
MYRIAD GENETICS INC$MYGN
Common Stock
2018-07-11$41.00/sh−2,346→ 332,175 total
Sale
MYRIAD GENETICS INC$MYGN
Common Stock
2018-05-30$38.00/sh−90,000→ 332,175 total
Exercise/Conversion
MYRIAD GENETICS INC$MYGN
Non-Qualified Stock Option (right to buy)
2018-05-30−90,000→ 0 total
Exercise/Conversion
MYRIAD GENETICS INC$MYGN
Common Stock
2018-05-30$22.93/sh+90,000→ 422,175 total
Disposition to Issuer
MYRIAD GENETICS INC$MYGN
Common Stock
2017-09-30$36.18/sh−9,238→ 332,175 total
Disposition to Issuer
MYRIAD GENETICS INC$MYGN
Common Stock
2017-09-30$36.18/sh−19,367→ 341,413 total
Disposition to Issuer
MYRIAD GENETICS INC$MYGN
Common Stock
2017-09-17$33.05/sh−11,671→ 360,780 total
Award
MYRIAD GENETICS INC$MYGN
Common Stock
2017-09-13+165,000→ 372,451 total
Disposition to Issuer
MYRIAD GENETICS INC$MYGN
Common Stock
2016-09-30$20.58/sh−9,238→ 207,451 total
Disposition to Issuer
MYRIAD GENETICS INC$MYGN
Common Stock
2016-09-17$20.92/sh−8,042→ 216,689 total
Award
MYRIAD GENETICS INC$MYGN
Common Stock
2016-09-14+78,705→ 224,731 total
Purchase
MYRIAD GENETICS INC$MYGN
Common Stock
2016-08-19$21.24/sh+10,000→ 146,026 total

Companies

Recent Filings

Address

C/O SERA PROGNOSTICS, INC. 2749 EAST PARLEYS WAY, SUITE 200

SALT LAKE CITY, UT, 84109

View on SEC.gov